Published in Cell Tissue Kinet on July 01, 1985
Thymidine kinase 1 is a better prognostic marker than Ki-67 for pT1 adenocarcinoma of the lung. Int J Clin Exp Med (2014) 0.82
Concentration-dependent effects of foscarnet on the cell cycle. Antimicrob Agents Chemother (1985) 0.77
Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits. J Biol Chem (1985) 2.47
Cell cycle-dependent regulation of mammalian ribonucleotide reductase. The S phase-correlated increase in subunit M2 is regulated by de novo protein synthesis. J Biol Chem (1984) 2.19
S-phase-specific expression of mammalian ribonucleotide reductase R1 and R2 subunit mRNAs. Biochemistry (1990) 2.07
Early detection of malignancy in ulcerative colitis. A flow-cytometric DNA study. Cancer (1984) 1.80
Ploidy and proliferation patterns in colo-rectal adenocarcinomas related to Dukes' classification and to histopathological differentiation. A flow-cytometric DNA study. Acta Pathol Microbiol Immunol Scand A (1983) 1.46
Colonoscopic surveillance in long-standing total ulcerative colitis--a 15-year follow-up study. Gastroenterology (1990) 1.43
Ploidy and proliferation in human bladder tumors as measured by flow-cytofluorometric DNA-analysis and its relations to histopathology and cytology. Cancer (1979) 1.37
Cell cycle regulation of immunoglobulin class switch recombination and germ-line transcription: potential role of Ets family members. Eur J Immunol (1995) 1.15
Cell proliferation and DNA content in non-Hodgkin's lymphoma. Flow cytometry in relation to lymphoma classification. Cancer (1986) 1.13
An improved Hedley method for preparation of paraffin-embedded tissues for flow cytometric analysis of ploidy and S-phase. Cytometry (1991) 1.10
The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours: a study of 100 untreated cases. Br J Urol (1982) 1.07
Expression of the neurotransmitter-synthesizing enzyme glutamic acid decarboxylase in male germ cells. Mol Cell Biol (1990) 1.07
Prognostic significance of flow cytometry studies in B-cell non-Hodgkin lymphoma. Hematol Oncol (1990) 1.05
Neoplastic transformation of the pelvic pouch mucosa in patients with ulcerative colitis. Gastroenterology (1997) 1.03
Flow cytofluorometric DNA analyses of metastases of human malignant melanomas. Anal Quant Cytol (1982) 1.01
Consensus report of the task force on standardisation of DNA flow cytometry in clinical pathology. DNA Flow Cytometry Task Force of the European Society for Analytical Cellular Pathology. Anal Cell Pathol (1998) 1.01
Thymidine kinase 1 is a potential marker for prognosis and monitoring the response to treatment of patients with breast, lung, and esophageal cancer and non-Hodgkin's lymphoma. Nucleosides Nucleotides Nucleic Acids (2010) 1.01
Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. Endoscopy (2002) 1.00
Dysplasia and DNA aneuploidy in a pelvic pouch. Report of a case. Dis Colon Rectum (1991) 1.00
p53 expression in epithelial ovarian neoplasms: relationship to clinical and pathological parameters, Ki-67 expression and flow cytometry. Gynecol Oncol (1994) 0.99
Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness. Cancer Res (1999) 0.98
S-phase fraction of 155 soft tissue sarcomas: correlation with clinical outcome. Cancer (1996) 0.94
Preparation of cell nuclei from fresh tissues for high-quality DNA flow cytometry. Cytometry (1993) 0.93
Flow cytometric DNA analysis in longstanding ulcerative colitis: a method of prediction of dysplasia and carcinoma development? Gut (1987) 0.93
Flow cytometric DNA analysis: a prognostic tool in non-Hodgkin's lymphoma. Leuk Res (1989) 0.93
Can DNA cytometry be used for evaluation of malignancy and premalignancy in bile duct strictures in primary sclerosing cholangitis? J Hepatol (2000) 0.93
Clinical DNA flow cytometry. Med Oncol Tumor Pharmacother (1984) 0.93
Investigation on cell proliferation with a new antibody against thymidine kinase 1. Anal Cell Pathol (2001) 0.92
Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization. Oncogene (1994) 0.91
Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation. Eur J Cell Biol (1996) 0.91
DNA ploidy and cell phase in human pituitary tumors. Cancer (1984) 0.91
DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis. A 10-year follow-up study. Dis Colon Rectum (1994) 0.91
The clinical significance of thymidine kinase 1 measurement in serum of breast cancer patients using anti-TK1 antibody. Int J Biol Markers (2000) 0.90
DNA profile and tumour progression in patients with superficial bladder tumours. Urol Res (1982) 0.90
Deoxyribonucleic acid profile and tumor progression in primary carcinoma in situ of the bladder: a study of 63 patients with grade 3 lesions. J Urol (1992) 0.89
Cell cycle-dependent regulation of the DNA-dependent protein kinase. Cell Prolif (1999) 0.89
DNA aneuploidy in ulcerative colitis: reproducibility, topographic distribution, and relation to dysplasia. Gastroenterology (1992) 0.88
Serum thymidine kinase 1 is a prognostic and monitoring factor in patients with non-small cell lung cancer. Oncol Rep (2005) 0.88
Flow-cytometric DNA analysis as a means for early detection of malignancy in patients with chronic ulcerative colitis. Gut (1984) 0.88
Carcinoma of the endometrium: do the nuclear grade and DNA ploidy provide more prognostic information than do the FIGO and WHO classifications? Int J Gynecol Pathol (1996) 0.88
Selenite and selenate inhibit human lymphocyte growth via different mechanisms. Cancer Res (1996) 0.88
Can 8-oxo-dG be used as a predictor for individual radiosensitivity? Int J Radiat Oncol Biol Phys (2001) 0.87
Tissue PSA from fine-needle biopsies of prostatic carcinoma as related to serum PSA, clinical stage, cytological grade, and DNA ploidy. Prostate (1999) 0.87
E2F mediates induction of the Sp1-controlled promoter of the human DNA polymerase epsilon B-subunit gene POLE2. Nucleic Acids Res (2001) 0.87
DNA microspectrophotometry of bone sarcomas in tissue sections as compared to imprint and flow DNA analysis. Cytometry (1986) 0.87
Quantitative flow-microfluorometric analysis of the DNA in cells from neoplasms of the urinary bladder: correlation of aneuploidy with histological grading and the cytological findings. Urol Res (1978) 0.87
Clinical utility of cellular DNA measurements in prostate carcinoma. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993. Scand J Urol Nephrol Suppl (1994) 0.87
Deoxyribonucleoside triphosphate metabolism and the mammalian cell cycle. Effects of hydroxyurea on mutant and wild-type mouse S49 T-lymphoma cells. Exp Cell Res (1987) 0.86
Quantitative analysis of antiviral drug toxicity in proliferating cells. Cell Biol Toxicol (1986) 0.86
Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas. Clin Cancer Res (2000) 0.86
Comparison of the Ki-67 score and S-phase fraction as prognostic variables in soft-tissue sarcoma. Br J Cancer (1999) 0.86
Morphometry of nuclei of the normal and malignant prostate in relation to DNA ploidy. Anal Quant Cytol Histol (1992) 0.85
Comparative single cell and flow DNA analysis in aspiration biopsies from breast carcinomas. Acta Pathol Microbiol Scand A (1980) 0.85
Cell cycle-dependent metabolism of pyrimidine deoxynucleoside triphosphates in CEM cells. J Biol Chem (1997) 0.85
DNA measurements of human pituitary tumours. Acta Otolaryngol Suppl (1981) 0.84
Chromosomal and DNA patterns in transitional cell bladder carcinoma. A comparative cytogenetic and flow-cytofluorometric DNA study. Cancer (1984) 0.84
Deoxyribonucleic acid analysis in the evaluation of transitional cell carcinoma before cystectomy. J Urol (1984) 0.84
Growth-regulatory properties of G1 cells synchronized by centrifugal elutriation. Exp Cell Res (1993) 0.84
A high proliferation rate measured by cyclin A predicts a favourable chemotherapy response in soft tissue sarcoma patients. Br J Cancer (1999) 0.84
Deoxyribonucleoside triphosphate metabolism and the mammalian cell cycle. Effects of thymidine on wild-type and dCMP deaminase-deficient mouse S49 T-lymphoma cells. Exp Cell Res (1984) 0.84
The prognostic value of modal deoxyribonucleic acid in low grade, low stage untreated prostate cancer. J Urol (1990) 0.84
Hydroxyurea-induced cell death as related to cell cycle in mouse and human T-lymphoma cells. Cancer Res (1987) 0.84
Characterization of malignant and non-neoplastic cell phenotypes in highly malignant non-Hodgkin lymphomas. Int J Cancer (1983) 0.83
Consensus review of the clinical utility of DNA cytometry in bladder cancer. Report of the DNA Cytometry Consensus Conference. Cytometry (1993) 0.83
Energy metabolism and ATP turnover time during the cell cycle of Ehrlich ascites tumour cells. Exp Cell Res (1982) 0.83
Ki-67 immunostaining and DNA flow cytometry as prognostic factors in epithelial ovarian cancers. Anticancer Res (1994) 0.83
Cell cycle related studies on thymidine kinase and its isoenzymes in Ehrlich ascites tumours. Cell Prolif (1991) 0.83
DNA content prognostic in soft tissue sarcoma. 102 patients followed for 1-10 years. Acta Orthop Scand (1991) 0.83
DNA flow analysis of soft tissue tumors. Cancer (1987) 0.83
Characterization of bladder carcinomas by flow DNA analysis. Eur Urol (1985) 0.83
Flow cytometric DNA and cytogenetic studies in human tumors: a comparison and discussion of the differences in modal values obtained by the two methods. Cytometry (1986) 0.83
p53 deletion as a genetic marker in urothelial tumor by fluorescence in situ hybridization. Cancer Res (1994) 0.83
DNA pattern, histological grade and multiplicity related to recurrence rate in superficial bladder tumours. Scand J Urol Nephrol (1982) 0.83
Increased activity of the eEF-2 specific, Ca2+ and calmodulin dependent protein kinase III during the S-phase in Ehrlich ascites cells. Biochem Biophys Res Commun (1991) 0.82
Comparison between radiation-induced cell cycle delay in lymphocytes and radiotherapy response in head and neck cancer. Br J Cancer (1998) 0.82
Endometrial carcinoma: the prognostic impact of papillary serous carcinoma (UPSC) in relation to nuclear grade, DNA ploidy and p53 expression. Anticancer Res (1996) 0.82
Flow DNA-cytometric findings of paraffin-embedded primary cutaneous melanomas related to prognosis. Virchows Arch B Cell Pathol Incl Mol Pathol (1989) 0.82
Comparative single-cell and flow DNA analysis of bone sarcoma. Anal Quant Cytol (1981) 0.81
Cell cycle dependent sensitivity of human melanoma cells to melphalan is correlated with the activity and cellular concentration of glutathione transferases. Carcinogenesis (1994) 0.81
Assessment of cell proliferation by Ki-67 staining and flow cytometry in fine needle aspirates (FNAs) of reactive lymphadenitis and non-Hodgkin's lymphomas. Cytopathology (1999) 0.81
X-irradiation effects on thymidine kinase (TK): I. TK1 and 2 in normal and malignant cells. Cell Prolif (2002) 0.81
Cell cycle arrest and DNA damage after melphalan treatment of the human myeloma cell line RPMI 8226. Eur J Haematol (1991) 0.81
Evaluation of tumor progression by repeated fine needle biopsies in prostate adenocarcinoma: modal deoxyribonucleic acid value and cytological differentiation. J Urol (1990) 0.81
Prognostic significance of flow cytometric and clinical variables in endometrial adenocarcinoma stages I and II. Anticancer Res (1992) 0.81
Effects of foscarnet on the cell kinetics of Madin-Darby canine kidney cells. Biochim Biophys Acta (1983) 0.81
Carcinoma and DNA aneuploidy in Crohn's colitis--a histological and flow cytometric study. Gut (1991) 0.81
Cell cycle distribution of proliferative and functional cells of the rat jejunum after treatment with oral E2 prostaglandins. Scand J Gastroenterol (1987) 0.81
Evaluation of tumor heterogeneity of prostate carcinoma by flow- and image DNA cytometry and histopathological grading. Anal Cell Pathol (2000) 0.81
Expression of glycolytic isoenzymes in activated human peripheral lymphocytes: cell cycle analysis using flow cytometry. Exp Cell Res (1991) 0.80